THINK Surgical completed enrollment for a U.S. investigational clinical study to support an FDA 510(k) to market the TSolution One® active robot for use in total knee replacement.
TSolution One uses a CT-based 3D pre-op planning program to virtually design and prepare for knee joint replacement using a selection of implant options. During surgery, the patient's planned surgery is implemented using the robot that prepares the joint.
THINK has received the CE Mark and presently markets TSolution One in Asia Pacific and European markets.
Source: THINK Surgical, Inc.